Table I.

The impact of line of treatment and haematological disease status on all‐cause death following diagnosis of COVID‐19.

	Total	Number of all‐cause deaths	OR (95% CI)	P value
No treatment	146	64 (44%)
First line	304	116 (38%)	1·15 (0·75,1·77)	0·52
Second line and beyond	194	97 (50%)	1·68 (1·07,2·64)	0·025
Never treated, asymptomatic	60	19 (32%)
Never treated, indication to treat now	50	25 (50%)	2·45 (1·09,5·5)	0·03
Treated with ongoing complete response or complete morphological remission	89	17 (19%)	0·84 (0·38,1·86)	0·67
Treated with some ongoing response	114	46 (40%)	1·97 (0·99,3·95)	0·055
Treated but with stable or progressive disease, relapse or not yet assessed	214	107 (50%)	3·21 (1·68,6·14)	<0·001

Age, sex and comorbidity status were included in the general linear model as covariates. Overall P‐value of line of treatment P = 0·049. Overall P value for impact of haematology disease status P < 0·001.